ALDA Pharmaceuticals Corp.
TSX VENTURE : APH

ALDA Pharmaceuticals Corp.

January 10, 2008 10:16 ET

ALDA Pharmaceuticals Receives First Samples From China

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 10, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("ALDA") has received the first product samples from China that have been manufactured by He-Yi She Ye Limited ("He-Yi") specifically for ALDA. The samples are general purpose wipes in canisters that will be filled with T36® Disinfectant for sale through ALDA's current distributors and with T36® "Ready to Use" Disinfectant Cleaner for retail sales under the new product identity being developed for ALDA. Dr. Terrance Owen, President & CEO, states, "These samples are an unexpected bonus resulting from ALDA's relationship with He-Yi. Our commercial customers have been asking us for some time to provide T36® Disinfectant Wipes but we were not able to obtain a suitable system in the quantities that we needed for a reasonable price. These new wipes and canisters from He-Yi will fill an important gap in our commercial product line and their addition to the retail line of products is also welcome. Over the next few weeks, we will be evaluating the samples we have received from He-Yi. Once we have given our approval, full production for sales in Canada and China will be scheduled".

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection control therapeutics derived from its patent-pending T36® technology. The company trades on the TSX Venture Exchange under the symbol APH.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • ALDA Pharmaceuticals Corp.
    Terrance G. Owen, Ph.D., MBA
    President, CEO and Director
    (604) 521-8300
    or
    ALDA Pharmaceuticals Corp.
    Peter Chen, CFO and Director
    Distribution & Sales Contact
    (604) 521-8300 Ext. 3
    (604) 521-8322 (FAX)
    Email: peter_chen@aldacorp.com
    or
    ALDA Pharmaceuticals Corp.
    Scott Young
    Investor Relations Contact
    (604) 288-7222
    Email: syoung@freeformcom.com
    Website: www.aldacorp.com